KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces intrauterine growth restriction in mice (Q44345560)

2 December 2017

KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces intrauterine growth restriction in mice (English)

1 reference

intrauterine growth restriction

2 December 2017

0 references

1 reference

6

1 reference

2 December 2017

Naomichi Abe

1

1 reference

2 December 2017

Tsutomu Nakahara

2

1 reference

2 December 2017

Akane Morita

3

1 reference

2 December 2017

Yoshiko Wada

4

1 reference

2 December 2017

Asami Mori

5

1 reference

2 December 2017

Tohru Nagamitsu

7

1 reference

2 December 2017

Kunio Ishii

8

1 reference

2 December 2017

18 June 2013

1 reference

Birth Defects Research Part B: Developmental and Reproductive Toxicology

2 December 2017

1 reference

2 December 2017

98

1 reference

2 December 2017

4

1 reference

2 December 2017

297-303

1 reference

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.

2 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

The fetal and infant origins of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Fetal growth restriction due to placental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Vascular endothelial growth factor: possible role in fetal development and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Lymphangiogenesis: Molecular mechanisms and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Effects of KRN633, an inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase, on vascular development of placenta and fetus of mid-pregnancy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.21064

21 January 2018

Identifiers

DOI

10.1002/BDRB.21064

1 reference

2 December 2017

1 reference